GB0025209A
GB0025209D0
(en)
|
2000-10-13 |
2000-10-13 |
Treatment of cancers
|
AU14023/01A
AU780417B2
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
PCT/GB2000/004349
WO2001035974A2
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
DE60035120T
DE60035120T2
(en)
|
1999-11-15 |
2000-11-15 |
TREATMENT OF CANCER DISORDERS BY APLIDINE
|
DK00976137T
DK1229922T3
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
ES00976137T
ES2288486T3
(en)
|
1999-11-15 |
2000-11-15 |
TREATMENT OF CANCERES WITH APLIDINA.
|
PL355335A
PL200922B1
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
NZ518847A
NZ518847A
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
KR10-2002-7006155A
KR100518986B1
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
CZ20021697A
CZ302498B6
(en)
|
1999-11-15 |
2000-11-15 |
Pharmaceutical composition containing aplidine for treating cancer diseases
|
AT00976137T
ATE363910T1
(en)
|
1999-11-15 |
2000-11-15 |
TREATMENT OF CANCER DISEASES BY APLIDINE
|
CA002391502A
CA2391502A1
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
EP00976137A
EP1229922B1
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
BR0015811-9A
BR0015811A
(en)
|
1999-11-15 |
2000-11-15 |
Treatment of cancers with aplidine
|
IL14948800A
IL149488A0
(en)
|
1999-11-15 |
2000-11-15 |
Pharmaceutical compositions containing aplidine
|
CN00818404A
CN1423564A
(en)
|
1999-11-15 |
2000-11-15 |
APLIDINE treatment of cancers
|
MXPA02004862A
MXPA02004862A
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers.
|
PT00976137T
PT1229922E
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
HU0203906A
HUP0203906A2
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
SK659-2002A
SK287762B6
(en)
|
1999-11-15 |
2000-11-15 |
Use of aplidine in preparation of pharmaceutical composition for treating cancer
|
SI200030960T
SI1229922T1
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment of cancers
|
RU2002115864/14A
RU2261104C2
(en)
|
1999-11-15 |
2000-11-15 |
Treatment of malignant tumor with aplidine
|
JP2001537965A
JP2003514025A
(en)
|
1999-11-15 |
2000-11-15 |
Aplidine treatment for cancer
|
CNA018204740A
CN1479622A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with myoprotector
|
CA002424823A
CA2424823A1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
AU2001294024A
AU2001294024C1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
HU0302293A
HUP0302293A3
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
AT01974510T
ATE299028T1
(en)
|
2000-10-12 |
2001-10-12 |
TREATMENT OF CANCER DISEASES WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
|
BR0114604-1A
BR0114604A
(en)
|
2000-10-12 |
2001-10-12 |
Cancer treatment
|
NZ525196A
NZ525196A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
US10/398,835
US7507766B2
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
AU9402401A
AU9402401A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
ES01974510T
ES2243555T3
(en)
|
2000-10-12 |
2001-10-12 |
CANCER TREATMENT BY APLIDINE IN CONJUNCTION WITH CARNITINE OR ACETILCARNITINE.
|
KR10-2003-7005081A
KR20030038812A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
MXPA03003230A
MXPA03003230A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector.
|
EP01974510A
EP1330254B1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with carnitine or acetylcarnitine
|
RU2003113210/14A
RU2003113210A
(en)
|
2000-10-12 |
2001-10-12 |
TREATMENT OF CANCER DISEASES
|
DE60111858T
DE60111858T2
(en)
|
2000-10-12 |
2001-10-12 |
TREATMENT OF CANCER DISORDERS WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
|
CZ2003993A
CZ2003993A3
(en)
|
2000-10-12 |
2001-10-12 |
Medicament for treating cancer by administration of aplidine or aplidine analog and bone musculature protector
|
PL01361179A
PL361179A1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
PCT/GB2001/004555
WO2002030441A2
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
IL15527301A
IL155273A0
(en)
|
2000-10-12 |
2001-10-12 |
Pharmaceutical compositions comprising an aplidine compound
|
JP2002533881A
JP2004510824A
(en)
|
2000-10-12 |
2001-10-12 |
Cancer Treatment
|
NO20022293A
NO330719B1
(en)
|
1999-11-15 |
2002-05-14 |
Use of aplidine in the manufacture of a pharmaceutical composition for the treatment of cancer in a human patient
|
BG106714A
BG65381B1
(en)
|
1999-11-15 |
2002-05-18 |
Use of aplidine in the preparation of a pharmaceutical composition for treatment of cancer
|
HK02106981.6A
HK1045648B
(en)
|
1999-11-15 |
2002-09-25 |
Aplidine treatment of cancers
|
NO20031673A
NO20031673L
(en)
|
2000-10-12 |
2003-04-11 |
Treatment of cancer
|
HK03106440.0A
HK1054191A1
(en)
|
2000-10-12 |
2003-09-10 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
CY20071101110T
CY1106825T1
(en)
|
1999-11-15 |
2007-08-30 |
TREATMENT OF CANCER WITH APLIDINE
|
US12/342,478
US20090298752A1
(en)
|
1999-11-15 |
2008-12-23 |
Aplidine treatment of cancers
|
JP2009255266A
JP2010031043A
(en)
|
2000-10-12 |
2009-11-06 |
Treatment of cancer
|